Skip to main content
. 2024 Apr 30;111(2):427–435. doi: 10.1093/biolre/ioae069

Figure 1.

Figure 1

Expression of RPPH1 using qPCR at weeks 22–24 and 36–38 measured in leukocytes (A), EVs (B), and plasma (C) between women who subsequently developed PE and controls (NP). Data, relative expression, are shown as EMM and 95% CI from linear mixed model analysis adjusting for age and BMI. The adjusted p-values (*) represent expression levels comparing RPPH1 between PE and controls at each timepoint, 22–24 and 36–38 weeks, from the linear mixed model analysis. *p-value < 0.05, ***p < 0.001.